Sexy Reps Sell Rx Drugs
"Known for their athleticism, postage-stamp skirts and persuasive enthusiasm, cheerleaders have many qualities the drug industry looks for in its sales force," according to an article in today's New York Times...
Pfizer Tries Unbranded ED DTC Ads
Despite what its own executives are saying to the FDA--i.e., unbranded DTC ads are not as effective as branded ads to drive consumers to doctors' offices (see "Why unbranded ads don't...
AstraZeneca’s Risky Proposition
AstraZeneca stunned attendees at the recent FDA hearings -- at least those "in the know" -- with an announcement that it submitted written testimony proposing "a mandatory requirement for pharmaceutical companies...
WSJ Cites PM Blog as “Must Read”
The Wall Street Journal, in the article "What the In-Crowd Knows", lists Pharma Marketing Blog as a blog insiders read to stay current. Here's what health reporter Laura Landro had to...
Plan B FDAgate
FDA's decision to block approval of OTC status for the Plan B contraceptive is rapidly becoming the center of an FDA controversy that has all the earmarks of a Watergate conspiracy....
Preview of Upcoming Articles
The following topics will be covered in depth in the upcoming November issue of Pharma Marketing News. Access the preview online at www.pharma-mkting.com/news/PMNissue410OnlinePreview.htm.DTC Pros and Cons Presented at FDA HearingePeople are...
Why unbranded ads don’t work
Patrick Kelly, President of Pfizer US Pharmaceuticals, who testified at the recent FDA public hearing on DTC, announced that Pfizer has allocated a portion of their media budget a financial amount...
FDA DTC Hearings Day 2
The second day of the FDA hearings on DTC was essentially more of the same as the first day. There were, however, a few nuggets here and there that I feel...
FDA DTC Hearings: Snippets from Day 1
I am in Washington, DC attending the FDA public hearing on DTC. I will try to summarize a few of the more interesting presentations here. Later, I will cover the proceedings...
DTC Regulation: Trick or Treat?
At a post-Halloween public hearing this week, the FDA will be soliciting public commentary about several direct-to-consumer (DTC) advertising techniques employed by pharmaceutical marketers. This process is scary to some pharma...
